Investor FAQs

What does Global Cord Blood Corporation do?

Our company provides umbilical cord blood storage services to enable parents to save the cord blood stem cells of their newborns to safeguard the lives and health of their children. We operate in China and the greater Asia Pacific region and were the first cord blood bank operator approved by the Ministry of Health of the People's Republic of China to engage in the cord blood banking business.

How many cord blood banking licenses does Global Cord Blood have access to in China?

We now have access to four cord blood banking licenses, which enable us to capitalize on the great market opportunities in the Beijing, Guangdong, Zhejiang and Shandong markets.

Where can I learn more about stem cell storage?

Please refer to the "Services" section of our website for detailed overview and services of cord blood banking services.

What is Global Cord Blood Corporation's ticker symbol and on what exchange does it trade?

We trade on the New York Stock Exchange under the ticker symbol, "CO."

Who is on Global Cord Blood Corporation's Board of Directors?

For a complete list of the members of our Board of Directors and their biographies, please visit the "Board of Directors" section in the "About GCBC " section on our website.

How can I find information on Global Cord Blood Corporation's SEC filings?

Our filings with the SEC may be obtained by accessing the "Financial Information" link in the "Investor Relations" section on our website or by visiting www.sec.gov.

When does Global Cord Blood Corporation's fiscal year end?

Our fiscal year ends on March 31.

Does management ever meet with investors outside of China, such as in the United States or Europe?

Yes, management will travel to the U.S. and Europe several times a year to present and meet with investors at conferences or through non-deal roadshows.

How can I be placed on the Global Cord Blood Corporation's e-mail news distribution list?

To be placed on the Company's e-mail news distribution list, please submit your request to our Investor Relations Department, whose contact information can be found in "IR Contact in the "Investor Relations" section on our website.

How can I contact management?

Please contact us through our Investor Relations department, whose details can be found in "IR Contact in the "Investor Relations" section on our website.

Are there any material differences in Global Cord Blood Corporation's corporate governance practices from those of U.S. domestic companies under the NYSE listing standards?

We are incorporated under the laws of the Cayman Islands, our home country, with securities publicly traded in the United States on the NYSE. The NYSE Rules permit foreign private issuers to follow applicable home country corporate governance practices in lieu of the NYSE corporate governance standards, subject to certain exceptions. Foreign private issuers electing to follow home country corporate governance rules are required to disclose the principal differences in their corporate governance practices from those required under the NYSE Rules. Except as set forth in the "Corporate Governance - Highlights" in the "Investor Relations" section in our website, there are no material differences in the Company's corporate governance practices from those of U.S. domestic companies under the listing standards of the NYSE.